UniQure gene therapy delivers lasting efficacy in hemB, but Spark FIX comparisons continue to cast a shadow over data – FierceBiotech
FierceBiotechUniQure gene therapy delivers lasting efficacy in hemB, but Spark FIX comparisons continue to cast a shadow over dataFierceBiotechUniQure has posted fresh data from a phase 1/2 trial of its hemophilia B gene therapy. The 12-month low-dose … Continue reading
